Rivaroxaban

Ibisobanuro bigufi:

Izina rya API Kwerekana Ibisobanuro DMF yo muri Amerika EU DMF CEP
Rivaroxaban Anticoagulant Mu nzu TDP    


Ibicuruzwa birambuye

Ibicuruzwa

KUBONA UMUSARURO

Amavu n'amavuko

Rivaroxaban, 5-chloro-N - [[(5S) -2-oxo-3- [4- -carboxamide, ni imbaraga ntoya ya molekile ikingira ibintu Xa nikintu coagulation mugihe gikomeye mumihanda ya coagulation yamaraso bigatuma habaho kubyara trombine no gushiraho imyenda. Rivaroxaban ihuza Tyr288 mu mufuka wa S1 w'ikintu Xa binyuze mu mikoranire ya Tyr288 hamwe na chlorine isimbuza chlorothiophene. Kubuzwa birashobora guhinduka (koff = 5x10-3s-1), byihuse (kon = 1.7x107 mol / L-1 s-1), kandi muburyo bushingiye ku kwibanda (Ki = 0.4 nmol / L). Muri iki gihe Rivaroxaban irimo kwigwa mu kuvura VTE, gukumira indwara zifata umutima n’umutima ku barwayi bafite syndrome ikaze ya coronary, kwirinda indwara y’imitsi ku barwayi bafite fibrillation yo mu mubiri.

Reba

Elisabeth Perzborn, Susanne Roehrig, Alexander Straub, Dagmar Kubitza, Wolfgang Mueck, na Volker Laux. Rivaroxaban: ikintu gishya cyo munwa Xa inhibitor. Arterioscler Thromb Vasc Biol 2010; 30 (3): 376-381

Ibisobanuro

Rivaroxaban (BAY 59-7939) nimbaraga nyinshiguhitamo no kuyobora Factor Xa (FXa) inhibitor, kugera ku nyungu zikomeye mubushobozi bwo kurwanya FXa (IC50 0.7 nM; Ki 0.4 nM).

 

Muri Vitro

Rivaroxaban (BAY 59-7939) ni umunwa, utaziguye Factor Xa (FXa) inhibitor mugutezimbere no gukumira no kuvura trombose ya arterial na venine. Rivaroxaban irushanwa irwanya abantu FXa (Ki 0.4 nM) hamwe na> 10 000 yikubye inshuro 10 kurenza izindi poroteyine za serine; irabuza kandi ibikorwa bya prothrombinase (IC50 2.1 nM). Rivaroxaban ibuza FXa endogenous cyane muri plasma yabantu ninkwavu (IC50 21 nM) kuruta plasma yimbeba (IC50 290 nM). Yerekana ingaruka za anticoagulant muri plasma yabantu, gukuba kabiri prothrombine (PT) kandi ikora tromboplastine igice cya 0.23 na 0.69μM, kimwe.

 

Rivaroxaban (BAY 59-7939) nimbaraga zikomeye kandi zitoranya, ziyobora FXa inhibitor hamwe nibikorwa byiza bya vivo hamwe na bioavailable yo mu kanwa. Rivaroxaban (BAY 59-7939), iyobowe na iv bolus mbere yo kwinjizwa kwa trombus, igabanya imiterere ya trombus (ED50 0.1 mg / kg), ikabuza FXa, kandi ikongerera PT urugero. PT na FXa bigira ingaruka nkeya kuri ED50 (kwiyongera inshuro 1.8 na 32% bibujijwe). Kuri 0.3 mg / kg (ikinini kiganisha hafi yo guhagarika trombus), Rivaroxaban yongerera PT mu buryo bushyize mu gaciro (3.2)±0.5-inshuro) kandi ibuza ibikorwa bya FXa (65±3%).

 

Ububiko

Ifu

-20 ° C.

Imyaka 3
 

4 ° C.

Imyaka 2
Mubishobora

-80 ° C.

Amezi 6
 

-20 ° C.

Ukwezi 1

Imiterere yimiti

Rivaroxaban

CERTIFICATE

2018 GMP-2
MP GMP 证书 201811 (capopril, thalidomide n'ibindi)
GMP-ya-PMDA-muri-Chanyoo- 平成 28 年 08 月 03 日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Ibaruwa-201901

Gucunga UMUNTU

Gucunga neza1

Icyifuzo18Imishinga yo gusuzuma ireme ryiza yemejwe4, na6imishinga iremezwa.

Gucunga neza2

Sisitemu mpuzamahanga yo gucunga neza ubuziranenge yashyizeho urufatiro rukomeye rwo kugurisha.

Gucunga neza3

Igenzura ryiza rinyura mubuzima bwose bwibicuruzwa kugirango hamenyekane ingaruka nziza nubuvuzi.

Gucunga neza4

Itsinda rishinzwe kugenzura ibikorwa byumwuga rishyigikira ubuziranenge busabwa mugihe cyo gusaba no kwiyandikisha.

Gucunga UMUSARURO

cpf5
cpf6

Koreya Countec Amacupa yo gupakira

cpf7
cpf8

Tayiwani CVC Icupa ryuzuye

cpf9
cpf10

Ubutaliyani CAM Ubuyobozi bwo gupakira

cpf11

Imashini yo Kudage Fette

cpf12

Ubuyapani Viswill Tablet Detector

cpf14-1

Icyumba cyo kugenzura DCS

UMufatanyabikorwa

Ubufatanye mpuzamahanga
Ubufatanye mpuzamahanga
Ubufatanye mu gihugu
Ubufatanye mu gihugu

  • Mbere:
  • Ibikurikira:

  • Andika ubutumwa bwawe hano hanyuma utwohereze

    Ibyiciro byibicuruzwa